title: A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy.
authors.affiliation: Tisch Cancer Institute, Mount Sinai School of Medicine, New York NY, USA. matthew.galsky@mssm.edu
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Galsky
authors.forename: Noah M
authors.initials: NM
authors.lastname: Hahn
authors.forename: Jonathan
authors.initials: J
authors.lastname: Rosenberg
authors.forename: Guru
authors.initials: G
authors.lastname: Sonpavde
authors.forename: Thomas
authors.initials: T
authors.lastname: Hutson
authors.forename: William K
authors.initials: WK
authors.lastname: Oh
authors.forename: Robert
authors.initials: R
authors.lastname: Dreicer
authors.forename: Nicholas
authors.initials: N
authors.lastname: Vogelzang
authors.forename: Cora
authors.initials: C
authors.lastname: Sternberg
authors.forename: Dean F
authors.initials: DF
authors.lastname: Bajorin
authors.forename: Joaquim
authors.initials: J
authors.lastname: Bellmunt
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D014571:Urologic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D019459:Urothelium / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin